Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests
Aaron L. Oom Davey Smith Kevan Akrami
Aaron Oom
Oom Aaron / Aaron L. Oom
ORCID: 0000-0003-3300-0333
MicroRNAs: Novel Players in Cancer Diagnosis and Therapies 10.1155/2014/959461
MicroRNA-200b targets protein kinase C  and suppresses triple-negative breast cancer metastasis 10.1093/carcin/bgu133
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches. 10.1016/j.immuni.2017.05.007
Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests 10.1038/s41598-017-05980-z
Untargeted mass spectrometry-based metabolomics approach unveils molecular changes in raw and processed foods and beverages 10.1016/j.foodchem.2019.125290
Comparative Analysis of T Cell Spatial Proteomics and the Influence of HIV Expression 10.1101/2021.03.17.435902
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity 10.1101/2021.04.06.438579
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity 10.1371/journal.ppat.1009519
Davey Smith
Smith Davey
ORCID: 0000-0003-3603-1733
HIV Drug Susceptibility Testing 10.1016/B978-012764051-8/50036-6
Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men 10.1097/QAD.0b013e32830bfed8
Codon volatility does not reflect selective pressure on the HIV-1 genome 10.1016/j.virol.2005.03.014
Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men 10.1093/cid/cit252
The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis 10.1097/QAD.0b013e32834d3cab
Neurobehavioral disturbances during acute and early HIV infection 10.1097/WNN.0000000000000084
Prevalence of Transmitted HIV Drug Resistance among Recently Infected Persons in San Diego, CA 1996-2013 10.1097/QAI.0000000000000831
Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection 10.1038/mi.2015.33
Short communication: Increase of HIV-1 K103N transmitted drug resistance and its association with Efavirenz use in South Korea 10.1089/aid.2014.0368
Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat 10.1007/s13365-011-0059-9
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement 10.1126/sciimmunol.aat7796
Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United States 10.1093/infdis/jit633
The prostate as a reservoir for HIV-1 10.1097/01.aids.0000131364.60081.01
Lack of neutralizing antibody response to HIV-1 predisposes to superinfection 10.1016/j.virol.2006.08.009
P. falciparum enhances HIV replication in an experimental malaria challenge system 10.1371/journal.pone.0039000
Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus 10.1097/00002030-200305020-00001
Etravirine and Rilpivirine Drug Resistance among HIV-1 Subtype C Infected Children Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens in South India 10.1089/aid.2016.0133
Effect of CMV and HIV transcription on CD57 and PD-1 T-cell expression during suppressive ART 10.1097/QAI.0000000000000936
No evidence of posttreatment control after early initiation of antiretroviral therapy 10.1097/QAD.0000000000000816
Patients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine 10.1089/aid.2009.0107
SHMT2 and the BRCC36/BRISC deubiquitinase regulate HIV-1 Tat K63-ubiquitylation and destruction by autophagy 10.1371/journal.ppat.1007071
Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA 10.1093/infdis/jis777
Protease polymorphisms in HIV-1 subtype CRF01-AE represent selection by antiretroviral therapy and host immune pressure 10.1097/QAD.0b013e3283350eef
Characteristics of recently HIV-infected men who use the internet to find male sex partners and sexual practices with those partners 10.1097/01.qai.0000243100.49899.2a
Estimating selection pressures on HIV-1 using phylogenetic likelihood models 10.1002/sim.3192
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection 10.1073/pnas.0504658102
Development and Validation of the San Diego Early Test Score to Predict Acute and Early HIV Infection Risk in Men Who Have Sex with Men 10.1093/cid/civ335
Standard vaccines increase HIV-1 transcription during antiretroviral therapy 10.1097/QAD.0000000000001201
Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection 10.1007/s13365-012-0141-y
Longitudinal viral dynamics in semen during early HIV infection 10.1093/cid/ciw784
Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4 + T cell activation during antiretroviral treatment 10.1128/JVI.00831-14
Using HIV networks to inform real time prevention interventions 10.1371/journal.pone.0098443
The Importance of Human Immunodeficiency Virus Research for Transgender and Gender-Nonbinary Individuals 10.1093/cid/cix990
Comparative analysis of cell-associated HIV DNA levels in cerebrospinal fluid and peripheral blood by droplet digital PCR 10.1371/journal.pone.0139510
Role of seminal shedding of herpesviruses in HIV type 1 transmission 10.1093/infdis/jis683
An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China 10.1007/s13365-012-0089-y
Pooled nucleic acid testing to detect antiretroviral treatment failure in HIV-infected patients in Mozambique 10.1097/QAI.0000000000000724
Primary meningococcal polyarthritis, cellulitis, and pneumonia in an elderly, immunocompetent woman 10.1097/00019048-199905000-00015
Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies 10.1186/s12977-017-0339-4
Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil 10.1007/s13365-013-0215-5
Upregulation of BST-2/tetherin by HIV infection In Vivo 10.1128/JVI.02451-12
Developing and evaluating comprehensive HIV infection control strategies: Issues and challenges 10.1086/651480
No substantial evidence for sexual transmission of minority HIV drug resistance mutations in men who have sex with men 10.1128/JVI.00769-17
Characterizing HIV transmission networks across the United States 10.1093/cid/cis612
Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults 10.1093/cid/ciw655
Erratum: Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant acinetobacter baumannii infection (American Society for Microbiology (2017) 61:10 (e00954-17) DOI: 10.1128/AAC.00954-17) 10.1128/AAC.02221-18
Molecular epidemiology identifies HIV transmission networks associated with younger age and heterosexual exposure among Korean individuals 10.1002/jmv.24523
Characteristics of resting-state functional connectivity in HIV-associated neurocognitive disorder 10.1371/journal.pone.0153493
HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing 10.1016/j.virol.2014.10.019
Number of mutations within CTL-defined epitopes of the hepatitis B Virus (HBV) core region is associated with HBV disease progression 10.1002/jmv.22226
The Sordid Affair Between Human Herpesvirus and HIV 10.1093/infdis/jiv148
Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy 10.1038/srep13179
The global transmission network of HIV-1 10.1093/infdis/jit524
HIV Transmission Networks in the San Diego-Tijuana Border Region 10.1016/j.ebiom.2015.07.024
Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico 10.1097/QAI.0b013e3181ff63d7
Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection 10.1086/510748
Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles 10.1097/QAD.0000000000001445
Subtype associations with HIV-associated neurocognitive disorder in China 10.1007/s13365-015-0377-4
Seminal shedding of CMV and HIV transmission among men who have sex with men 10.3390/ijerph120707585
Can research at the end of life be a useful tool to advance HIV cure? 10.1097/QAD.0000000000001300
Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART 10.1038/srep17094
The dynamics of the HIV epidemic among men who have sex with men (MSM) from 2005 to 2012 in Shenzhen, China 10.1038/srep28703
Dual-mixed HIV-1 coreceptor tropism and HIV-associated neurocognitive deficits 10.1007/s13365-013-0203-9
Lyophilized visually readable loop-mediated isothermal reverse transcriptase nucleic acid amplification test for detection Ebola Zaire RNA 10.1016/j.jviromet.2017.02.013
Using HIV Sequence and epidemiologic data to assess the effect of self-referral testing for acute HIV infection on incident diagnoses in San Diego, California 10.1093/cid/ciw161
Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells 10.1016/j.virol.2012.09.010
Virologic correlates of Anti-CMV IgG levels in HIV-1-infected men 10.1093/infdis/jit434
Herd Immunity Likely Protected the Men Who Have Sex With Men in the Recent Hepatitis A Outbreak in San Diego, California 10.1093/cid/ciy592
Genetic attributes of blood-derived subtype-C HIV-1 tat and env in India and neurocognitive function 10.1002/jmv.23816
Hepatitis B virus compartmentalization in the cerebrospinal fluid of HIV-infected patients 10.1016/j.cmi.2014.11.012
HIV migration between blood and cerebrospinal fluid or semen over time 10.1093/infdis/jit678
Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract 10.1097/QAD.0b013e3283573305
A practical online tool to estimate antiretroviral coverage for HIV infected and susceptible populations needed to reduce local HIV epidemics 10.1038/srep28707
Corrigendum: Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART. 10.1038/srep19387
Less is more: an adaptive branch-site random effects model for efficient detection of episodic diversifying selection. 10.1093/molbev/msv022
Prevalence and T-cell phenotype of slow HIV disease progressors with robust HIV replication 10.1097/QAI.0b013e3181b08d70
First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar 10.1080/21505594.2016.1226722
Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men 10.1097/QAD.0b013e32834dcd26
Serosorting can potentially increase HIV transmissions 10.1097/QAD.0b013e32814db7bf
HIV-1 Clade B pol Evolution following Primary Infection 10.1371/journal.pone.0068188
Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection 10.1128/JVI.02579-07
Short Communication: HIV-1 Transmission Networks Across South Korea 10.1089/aid.2016.0212
Human immunodeficiency virus type 1 clade B superinfection: Evidence for differential immune containment of distinct clade B strains 10.1128/JVI.79.2.860-868.2005
Differences in tuberculin reactivity as determined in a veterans administration employee health screening program 10.1128/CVI.00375-08
Baseline Genotype Testing to Assess Drug Resistance before Beginning HIV Treatment - Reply 10.1001/jama.2018.15946
Shedding of hepatitis C virus in semen of human immunodeficiency virus-infected men 10.1093/ofid/ofw057
A woman kicked in the head by a horse 10.1097/00019048-200201000-00007
Partner services in adults with acute and early HIV infection 10.1097/QAD.0000000000001308
The efficiency of single genome amplification and sequencing is improved by quantitation and use of a bioinformatics tool 10.1016/j.jviromet.2009.08.002
Growth of HIV-1 molecular transmission clusters in New York City 10.1093/infdis/jiy431
Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting 10.1093/cid/ciq084
A public health model for the molecular surveillance of HIV transmission in San Diego, California 10.1097/QAD.0b013e32831d2a81
Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection 10.1016/j.jneuroim.2016.10.009
Correlates of HIV and malaria co-infection in Southern India 10.1186/1475-2875-11-306
Mathematical modeling of HIV prevention measures including pre-exposure prophylaxis on HIV incidence in South Korea 10.1371/journal.pone.0090080
Tissue-specific HIV-1 infection: Why it matters 10.2217/fvl.11.48
Reply to Mounzer and DiNubile 10.1093/infdis/jit218
Active duty military personnel presenting for care at a Gay Men's health clinic 10.1080/00918360801982173
Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations 10.1371/journal.ppat.1006112
Targeting HIV prevention based on molecular epidemiology among deeply sampled subnetworks of men who have sex with men 10.1093/cid/civ526
Asymptomatic CMV replication during early Human Immunodeficiency Virus (HIV) infection is associated with lower CD4/CD8 ratio during HIV treatment 10.1093/cid/ciw612
Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance 10.1097/QAD.0b013e3282f5ff71
Running with scissors: Using antiretroviral therapy without monitoring viral load 10.1086/587110
HIV drug resistance acquired through superinfection 10.1097/
Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance 10.1016/j.virol.2009.08.007
A longitudinal systems immunologic investigation of acute Zika virus infection in an individual infected while traveling to Caracas, Venezuela 10.1371/journal.pntd.0007053
Occult HBV infection in HIV-infected adults and evaluation of pooled NAT for HBV 10.1111/jvh.12858
Associations between virologic and immunologic dynamics in blood and in the male genital tract 10.1128/JVI.06077-11
Echinococcosis: A drop of water - Review on human disease, diagnosis, and management 10.1097/00019048-200109000-00003
Social and Genetic Networks of HIV-1 Transmission in New York City 10.1371/journal.ppat.1006000
Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California 10.1093/infdis/jis231
Universal HIV testing: Is it enough? 10.1086/522760
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage 10.1016/j.immuni.2017.11.002
Neurocognitive change in the era of HIV combination antiretroviral therapy: The longitudinal CHARTER study 10.1093/cid/ciu862
Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study) 10.1007/s10461-014-0845-5
Resting cerebral blood flow: A potential biomarker of the effects of HIV in the brain 10.1212/WNL.0b013e3181b59a97
Suicide risk behaviors among sexual minority adolescents in the United States, 2015 10.1001/jama.2017.16908
Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy 10.1056/NEJMoa1110187
Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations 10.1016/j.virol.2008.11.010
Continue antiretroviral therapy during virologic failure? 10.1086/338017
Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection 10.1128/JVI.02260-13
Physicians' attitudes toward homosexuality and HIV: Survey of a California medical society- Revisited (PATHH-II) 10.1300/J082v52n03_01
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine 10.1093/infdis/jit114
HIV-1 reverse transcriptase nucleotide substitutions in subtype C-infected, drug-naive, and treatment-experienced patients in South India 10.1097/QAI.0b013e318232a13c
Evaluation of an HIV nucleic acid testing program with automated internet and voicemail systems to deliver results 10.7326/0003-4819-152-12-201006150-00005
Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals 10.1001/jamainternmed.2014.4010
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis 10.1371/journal.pmed.1001810
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment 10.1016/j.virol.2012.08.028
Willingness to participate in HIV research at the end of life (EOL) 10.1371/journal.pone.0199670
Antibody response to achromobacter xylosoxidans during HIV infection is associated with lower CD4 levels and increased lymphocyte activation 10.1128/CVI.00553-13
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders 10.1007/s13365-013-0152-3
Darunavir is a good third-line antiretroviral agent for HIV type 1-infected patients failing second-line protease inhibitor-based regimens in South India 10.1089/aid.2011.0334
Etravirine in CSF is highly protein bound 10.1093/jac/dks517
Antigen-presenting phagocytic cells ingest malaria parasites and increase hiv replication in a tumor necrosis factor α-dependent manner 10.1093/infdis/jiu317
Viral pneumonia as a serious complication of etanercept therapy [2] 10.7326/0003-4819-136-2-200201150-00020
Colorectal disorders in acute human immunodeficiency virus infection: A case series 10.1093/ofid/ofw014
Semen-specific genetic characteristics of human immunodeficiency virus type 1 env 10.1128/JVI.79.3.1734-1742.2005
The control of HIV after antiretroviral medication pause (CHAMP) study: Posttreatment controllers identified from 14 clinical studies 10.1093/infdis/jiy479
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence 10.1073/pnas.0736332100
The need for treatment interruption studies and biomarker identification in the search for an HIV cure 10.1097/QAD.0000000000000658
Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV Levels 10.1097/QAI.0b013e318163bd87
HIV-associated neurocognitive disorder in HIV-infected Koreans: The Korean NeuroAIDS Project 10.1111/hiv.12137
The controversies of nevirapine for preventing mother-to-child HIV transmission 10.1097/01.aids.0000198095.00820.82
HIV migration between blood plasma and cellular subsets before and after HIV therapy 10.1002/jmv.24375
Detection of HIV-1 in alternative specimen types using the APTIMA ® HIV-1 RNA Qualitative Assay 10.1016/j.jviromet.2009.02.015
Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence 10.1371/journal.pone.0102555
Mechanism of action of methotrexate against zika virus 10.3390/v11040338
Replication of human herpesviruses is associated with higher HIV DNA levels during antiretroviral therapy started at early phases of HIV infection 10.1128/JVI.02638-15
Gene-wide identification of episodic selection 10.1093/molbev/msv035
Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors 10.1097/QAD.0000000000001716
Unusual insertion and deletion at codon 67 and 69 of HIV type 1 subtype C reverse transcriptase among first-line highly active antiretroviral treatment-failing south Indian patients: Association with other resistance mutations 10.1089/aid.2011.0331
Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests 10.1038/s41598-017-05980-z
IDEPI: Rapid Prediction of HIV-1 Antibody Epitopes and Other Phenotypic Features from Sequence Data Using a Flexible Machine Learning Platform 10.1371/journal.pcbi.1003842
Fatal Saccharomyces cerevisiae aortic graft infection 10.1128/JCM.40.7.2691-2692.2002
HIV superinfection 10.1086/431682
High prevalence of hepatitis delta virus among patients with chronic hepatitis B Virus infection and HIV-1 in an intermediate hepatitis B virus endemic region 10.1177/2325957413488166
HIV-1 drug resistance before initiation or re-initiation of first-line ART in eight regions of Mexico: A sub-nationally representative survey 10.1093/jac/dky512
Incidence of HIV superinfection following primary infection [5] 10.1001/jama.292.10.1177
Ethical considerations for HIV cure-related research at the end of life 10.1186/s12910-018-0321-2
Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: Implications for secondary transmission 10.1086/519164
Differences in evolution of HIV-1 subtype C reverse transcriptase between children and adults likely explained by maturity of cytotoxic T-lymphocyte responses 10.1089/aid.2015.0023
Gene expression before haart initiation predicts hiv-infected individuals at risk of poor cd4+ t-cell recovery 10.1097/QAD.0b013e328334f1f0
Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen 10.1002/jmv.23398
Reply to Haddow et al 10.1093/cid/civ045
Seminal plasma HIV levels in men with asymptomatic sexually transmitted infections 10.1258/ijsa.2009.009331
Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection 10.1007/s13365-015-0384-5
A novel codon insert in protease of clade B HIV type 1 10.1089/aid.2008.0310
Identification of Two New HIV-1 Circulating Recombinant Forms (CRF87_cpx and CRF88_BC) from Reported Unique Recombinant Forms in Asia 10.1089/AID.2016.0252
HIV Prevalence and Risk Behaviors in Male to Female (MTF) Transgender Persons in Tijuana, Mexico 10.1007/s10461-017-1931-2
Evolutionary origins of human herpes simplex viruses 1 and 2 10.1093/molbev/msu185
Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure 10.1016/j.jcv.2014.11.014
Repeat HIV-testing is associated with an increase in behavioral risk among men who have sex with men: A cohort study 10.1186/s12916-015-0458-5
Short communication: Prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients 10.1089/aid.2013.0227
Simulation of pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection in Seoul, South Korea 10.1097/QAI.0b013e31827e8cc8
Editorial commentary: HIV treatment decisions and transmitted drug resistance 10.1086/431215
Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection 10.1128/JCM.00106-12
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis 10.1371/journal.pmed.1001845
Global NeuroAIDS roundtable 10.1007/s13365-012-0143-9
Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1 10.1128/JVI.01793-06
The association between HIV-1 subtype C antiretroviral resistance and HLA prevalence in Southern India 10.1097/QAI.0b013e3182169050
The relatedness of HIV epidemics in the United States-Mexico border region 10.1089/aid.2010.0021
The use of high performance liquid chromatography to speciate and characterize the epidemiology of mycobacteria 10.1309/LMDDEHPSYE6ZDM3C
Mutations in the major hydrophilic region (MHR) of Hepatitis B virus genotype C in North China 10.1002/jmv.23419
Upregulation of BST-2/Tetherin by HIV infection in vivo 10.1128/JVI.05524-11
Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection 10.1086/513568
Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection in Seoul, South Korea 10.3109/00365548.2013.851415
Real-world impact of neurocognitive deficits in acute and early HIV infection 10.1007/s13365-013-0218-2
Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissions 10.1016/j.jinf.2016.07.019
Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection 10.1097/QAD.0000000000000964
Cerebrospinal fluid can be used for HIV genotyping when it fails in blood,O líquido cefalorraquidiano pode ser usado para a genotipagem do HIV quando esta não é possível no plasma 10.1590/0004-282X20140093
Genital cytomegalovirus replication predicts syphilis acquisition among HIV-1 infected men who have sex with men 10.1371/journal.pone.0130410
Molecular Features of the V1-V4 Coding Region of Sexually Transmitted Human Immunodeficiency Virus Type 1 10.1093/infdis/jix184
Impact of public safety policies on human immunodeficiency virus transmission dynamics in Tijuana, Mexico 10.1093/cid/cix884
Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China 10.1007/s13365-013-0150-5
HIV Trafficking between Blood and Semen during Early Untreated HIV Infection 10.1097/QAI.0000000000001156
Neurocognitive functioning in acute or early HIV infection 10.1007/s13365-010-0009-y
Evaluation of pooled rapid HIV antibody screening of patients admitted to a San Diego Hospital 10.1016/j.jviromet.2011.04.002
Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy 10.1097/QAI.0000000000001829
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy 10.1128/JVI.79.3.1772-1788.2005
Novel codon insert in HIV type 1 clade B reverse transcriptase associated with low-level viremia during antiretroviral therapy 10.1089/aid.2013.0202
Mycobacterium szulgai causing knee abscess and osteomyelitis in a patient with acquired immunodeficiency syndrome and subsequent immune reconstitution syndrome 10.1097/01.idc.0000214370.54423.2f
Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection 10.1128/AAC.00954-17
Mitochondrial injury and cognitive function in HIV infection and methamphetamine use 10.1097/QAD.0000000000001027
Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B 10.1007/s13365-016-0437-4
Deep sequencing reveals minor protease resistance mutations in Patients failing a protease inhibitor regimen 10.1128/JVI.06541-11
The origins of sexually transmitted HIV among men who have sex with men 10.1126/scitranslmed.3000447
Phylogenetic relatedness of HIV-1 Donor and recipient populations 10.1093/infdis/jit021
Size, composition, and evolution of HIV DNA populations during early antiretroviral therapy and intensification with maraviroc 10.1128/JVI.01589-17
Detection of minority resistance during early HIV-1 infection: Natural variation and spurious detection rather than transmission and evolution of multiple viral variants 10.1128/JVI.02582-10
Strengthening research capacity through the medical education partnership initiative: The Mozambique experience 10.1186/1478-4491-11-62
A combined screening platform for HIV treatment failure and resistance 10.1371/journal.pone.0035401
Genetic attributes of cerebrospinal fluid-derived HIV-1 env 10.1093/brain/awl136
Antiretroviral drugs for treatment and prevention of HIV infection in Adults: 2016 recommendations of the international antiviral society-USA Panel 10.1001/jama.2016.8900
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline 10.1212/WNL.0000000000000492
First Appearance of HIV-1 CRF07-BC and CRF08-BC Outside China 10.1089/aid.2016.0169
Comparison of methods to detect HIV dual infection 10.1089/aid.2010.0042
HIV Prevention Method Preferences Within Sexual Partnerships Reported by HIV-Negative MSM and TW in Tijuana, Mexico 10.1007/s10461-019-02492-x
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: Association of immune activation, T cell maturation markers, and cellular HIV-1 DNA 10.1086/504718
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international antiviral society-USA panel 10.1001/jama.2018.8431
HIV, Hepatitis B Virus, and Hepatitis C Virus Prevalence among High-Risk Populations in South India 10.1089/aid.2017.0253
Community HIV-1 drug resistance is associated with transmitted drug resistance 10.1111/hiv.12122
Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization—case study 10.1007/s13365-017-0518-z
Clear links between starting methamphetamine and increasing sexual risk behavior: A cohort study among men who have sex with men 10.1097/QAI.0000000000000888
Timing Matters - Influenza Vaccination to HIV-Infected Patients 10.1111/hiv.12360
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary Hepatitis C virus infection 10.1093/cid/cis1206
Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection 10.1097/QAD.0000000000000149
HIV-associated neurocognitive disorder is associated with HIV-1 dual infection 10.1097/QAD.0000000000001237
Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection 10.1097/QAI.0b013e3181ba37a7
Now is the Time to Study the Timing of Influenza Vaccine 10.1111/hiv.12486
Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics 10.1007/s13365-018-0672-y
Are all subtypes created equal? the effectiveness of antiretroviral therapy against non-subtype B HIV-1 10.1086/598503
Short report: Malaria diagnosis by a polymerase chain reaction-based assay using a pooling strategy 10.4269/ajtmh.2009.09-0274
Challenges in Quantifying Cytosine Methylation in the HIV Provirus 10.1128/mBio.02268-18
Reverse transcriptase substitution at codons 208 and 228 among treatment-experienced HIV-1 subtype-C-infected indian patients is strongly associated with thymidine analogue mutations 10.1097/QAI.0b013e31823e2d2b
Using phylogeography to characterize the origins of the HIV-1 subtype F epidemic in Romania 10.1016/j.meegid.2011.03.009
Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection 10.1097/QAD.0b013e3283611816
Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infection 10.1093/infdis/jit168
Molecular and pathologic insights from latent HIV-1 infection in the human brain 10.1212/WNL.0b013e31828c2e9e
A randomized controlled clinical trial on the impact of CCR5 blockade with maraviroc in early infection on T-cell dynamics 10.1097/MD.0000000000005315
A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines 10.1016/j.canlet.2015.12.008
Signs or symptoms of acute HIV infection in a cohort undergoing community-based screening 10.3201/eid2203.151607
(1→3)-β-D-Glucan: A biomarker for microbial translocation in individuals with acute or early HIV infection? 10.3389/fimmu.2016.00404
Primary incidence of Hepatitis C virus infection among HIV-infected men who have sex with men in San Diego, 2000-2015 10.1093/ofid/ofz160
In-depth sampling of high-risk populations to characterize HIV transmission epidemics among young MSM using PrEP in France and Quebec 10.1093/ofid/ofz080
The use of pooled viral load testing to identify antiretroviral treatment failure. 10.1097/QAD.0b013e3283313ca9
Response to Comment on "The Origins of Sexually Transmitted HIV Among Men Who Have Sex with Men" 10.1126/scitranslmed.3001473
Demyelinating Encephalitis 10.1086/374893
Chipping Away at HIV Pathogenesis 10.1007/978-1-59259-172-5_2
Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration. 10.2174/1874613600701010005
An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. 10.1038/mi.2013.116
Rapid Sequencing of Complete env Genes from Primary HIV-1 Samples. 10.1093/ve/vew018
Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM. 10.1093/ve/vew012
Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy. 10.1093/ve/vew020
Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response. 10.1128/JVI.00475-17
Trends in Internet Searches for Cannabidiol (CBD) in the United States. 10.1001/jamanetworkopen.2019.13853
Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection. 10.1371/journal.pone.0217964
Requests for Diagnoses of Sexually Transmitted Diseases on a Social Media Platform. 10.1001/jama.2019.14390
Proliferative memory SAMHD1low CD4+ T cells harbour high levels of HIV-1 with compartmentalized viral populations. 10.1371/journal.ppat.1007868